摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dithiobissuccinimide | 34251-41-7

中文名称
——
中文别名
——
英文名称
dithiobissuccinimide
英文别名
N,N'-Dithio-bis-succinimid;N,N'-Dithiobissuccinimid;N,N'-Dithiodisuccinimid;Disuccinimid-disulfid;N,N'-dithiodisuccinimide;1-[(2,5-dioxopyrrolidin-1-yl)disulfanyl]pyrrolidine-2,5-dione
dithiobissuccinimide化学式
CAS
34251-41-7
化学式
C8H8N2O4S2
mdl
——
分子量
260.295
InChiKey
NNBDOKBAFDDCHD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    125
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    dithiobissuccinimide 以3%的产率得到
    参考文献:
    名称:
    BOMBALA M. U.; LEY S. V., J. CHEM. SOC. PERKIN TRANS., PART 1, 1979, NO 12, 3013-3016
    摘要:
    DOI:
  • 作为产物:
    描述:
    丁二酰亚胺二氯化二硫三乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 0.02h, 以46%的产率得到dithiobissuccinimide
    参考文献:
    名称:
    New Polymers Possessing a Disulfide Bond in a Unique Environment
    摘要:
    The synthesis and some of the physical properties of the first poly(disulfidediamines) are reported. The disulfidediamine functional group (R2NSSNR2) possesses a disulfide bond in a unique environment that leads to a low bond dissociation energy (calculated BDE of 43.1 kcal mol(-1)). These polymers were synthesized in high yields and with conversions up to >98% by reactions between secondary diamines and a new disulfide monomer. The disulfide monomer was synthesized in two steps without the need for column chromatography. The polymerizations were robust and completed at room temperature, under ambient atmospheric conditions, and in solvents that were used as purchased. These polymers were stable, but they rapidly decomposed under acidic, aqueous conditions or by heating to 175 degrees C as shown by thermal gravimetric analysis. The first fully conjugated poly(disulfidediamine) was synthesized, and its electrical conductivity was characterized in the solid state.
    DOI:
    10.1021/ma3017103
点击查看最新优质反应信息

文献信息

  • [EN] SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE<br/>[FR] RADIOFLUORATION SPÉCIFIQUE DE SITE DE PEPTIDES AVEC DE L'ACIDE 8-[18F]FLUOROOCTANOÏQUE CATALYSÉE PAR UNE ACIDE LIPOÏQUE LIGASE
    申请人:UNIV CALIFORNIA
    公开号:WO2017095806A1
    公开(公告)日:2017-06-08
    New methodologies for site-specifically radiolabeling proteins with the PET isotope [18F] are required to generate high quality radiotracers for imaging in both the preclinical and clinical settings. The enzymatic radiofluorination overcomes many of the limitations encountered to date with purely chemical approaches. The bacterial enzyme lipoic acid ligase was used to conjugate [18F]-fluorooctanoic acid to both a small peptide and a Fab antibody fragment. Labeling was site-specific and highly efficient under mild aqueous conditions using small amounts of peptide/protein (1-10 nmol). The labeled construct retained full epitope binding affinity and was stable in mouse serum. Using an optimized reaction scheme, mCi quantities of [18F]-Fab were generated, an amount sufficient for human imaging.
    用PET同位素[18F]对蛋白质进行特异性标记的新方法对于在临床前和临床环境中生成高质量放射示踪剂是必需的。酶促放反应克服了迄今为止纯化学方法所遇到的许多限制。细菌酶辛酸连接酶被用于将[18F]-辛酸与小肽和Fab抗体片段结合。在温和性条件下,使用少量的肽/蛋白质(1-10 nmol),标记是特异性的且高效的。标记的构建物保留了完整的抗原结合亲和力,并在小鼠血清中稳定。使用优化的反应方案,产生了足够进行人体成像的mCi数量的[18F]-Fab。
  • Methods and compositions for protein labeling using lipoic acid ligases
    申请人:Ting Alice Y.
    公开号:US20090149631A1
    公开(公告)日:2009-06-11
    The invention provides compositions and methods of use thereof for labeling peptide and proteins in vitro or in vivo. The methods described herein employ lipoic acid ligase or mutants thereof, and lipoic acid analogs recognized by lipoic acid ligase and lipoic acid ligase mutants.
    本发明提供了一种用于体外或体内标记多肽和蛋白质的组合物及其使用方法。所述方法采用辛酸连接酶或其突变体,以及被辛酸连接酶和辛酸连接酶突变体所识别的辛酸类似物。
  • PROBE INCORPORATION MEDIATED BY ENZYMES
    申请人:TING ALICE Y.
    公开号:US20120214201A1
    公开(公告)日:2012-08-23
    The invention provides compositions and methods of use thereof for labeling peptide and proteins in vitro or in vivo. The methods described herein employ lipoic acid ligase or mutants thereof, and lipoic acid analogs recognized by lipoic acid ligase and lipoic acid ligase mutants.
    本发明提供了用于体外或体内标记肽和蛋白质的组合物和使用方法。本文所描述的方法采用辛酸连接酶或其突变体以及辛酸类似物,这些类似物被辛酸连接酶和辛酸连接酶突变体所识别。
  • METHODS AND COMPOSITIONS FOR PROTEIN LABELING USING LIPOIC ACID LIGASES
    申请人:Ting Alice Y.
    公开号:US20120129159A1
    公开(公告)日:2012-05-24
    The present disclosure provides compositions and methods of use thereof for labeling peptide and proteins in vitro or in vivo. The methods described herein employ lipoic acid ligase or mutants thereof, and lipoic acid analogs (e.g., lipoic acid analogs comprising a resorufin moiety) recognized by lipoic acid ligase and lipoic acid ligase mutants. Also provided herein is a method of imaging protein-protein interaction via a reaction mediated by lipoic acid ligase.
    本公开提供了用于体外或体内标记肽和蛋白质的组合物和使用方法。本文所描述的方法采用辛酸连接酶或其突变体,以及辛酸类似物(例如,包含酮酸染料基团的辛酸类似物),这些类似物被辛酸连接酶和辛酸连接酶突变体所识别。本文还提供了一种通过辛酸连接酶介导的反应来成像蛋白质相互作用的方法。
  • Methods of Screening for Modified Antibodies With Agonistic Activities
    申请人:Nakano Kiyotaka
    公开号:US20070281327A1
    公开(公告)日:2007-12-06
    Anti-human Mpl antibodies were prepared, and from these three types of antibodies with strong binding activity were selected. An expression system for single-chain antibodies derived from these selected antibodies was constructed using genetic engineering techniques. The anti-human Mpl antibodies and anti-human Mpl single-chain antibodies were assessed for TPO-like agonist activity using BaF3-human Mpl that proliferates TPO-dependently. It was found that while the anti-human Mpl antibodies did not exhibit agonistic activity, the anti-human Mpl single-chain antibodies showed agonistic activity. This shows that when screening for modified antibodies with agonistic activity, it is beneficial to determine agonistic activity after modifying antibodies with antigen-binding activity.
    制备了抗人Mpl抗体,并从中选择了三种具有强结合活性的抗体。利用基因工程技术构建了由这些选定抗体衍生的单链抗体的表达系统。使用BaF3-human Mpl评估了抗人Mpl抗体和抗人Mpl单链抗体的TPO样激动剂活性,该细胞系依赖于TPO增殖。结果发现,抗人Mpl抗体未表现出激动剂活性,而抗人Mpl单链抗体则表现出激动剂活性。这表明,在筛选具有激动剂活性的修饰抗体时,有利的做法是在修饰抗原结合活性后确定激动剂活性。
查看更多

同类化合物

(5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基酰肼盐酸盐 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG6-丙酸 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-四聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-六聚乙二醇-羧酸 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-八聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式草酸双(-3,8-二氮杂双环[4.2.0]辛烷-8-羧酸叔丁酯) 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式4-氟吡咯烷酮-3-醇盐酸盐 顺式3,4-二羟基吡咯烷盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-5-甲基-1H-六氢吡咯并[3,4-b]吡咯二盐酸盐 顺式-5-氧代六氢环戊二烯并[c]吡咯-2(1H)-羧酸叔丁酯 顺式-5-乙氧羰基-1H-六氢吡咯并[3,4-B]吡咯盐酸盐 顺式-5-(碘甲基)-4-苯基-2-吡咯烷酮 顺式-5-(碘甲基)-4-甲基-2-吡咯烷酮 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-1-甲基六氢吡咯并[3,4-b]吡咯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁